文献速递传染病防控与疫情报告职业卫生

罗马某三级医院由产NDM-1和OXA-48的肺炎克雷伯菌ST147引起的医院暴发

Hospital outbreak sustained by Klebsiella pneumoniae sequence type 147 co-producing NDM-1 and OXA-48, Rome, Italy, February to March 2025: molecular tracing and control measures.
PubMed 文献 · Euro Surveill · 2026-01-01

快速感染防控措施帮助遏制传播,但暴发仍跨病区扩散;纳米孔测序(NanoTyping)联合全基因组测序确认高风险ST147克隆克隆传播。

要点

  • 共产NDM-1和OXA-48的肺炎克雷伯菌ST147可在重症监护病房引起医院暴发。
  • 常规或强化直肠拭子筛查有助于发现暴发菌株定植或感染患者。
  • 快速分子分型联合全基因组测序可支持实时暴发调查与响应。

核心结论

  • 本次暴发由共产NDM-1和OXA-48碳青霉烯酶的肺炎克雷伯菌ST147克隆引起,基因组监测与快速诊断对实时响应至关重要。

研究设计与样本

  • 采用院内纳米孔测序方案(NanoTyping)快速分子分型,并辅以全基因组测序确认克隆传播。
  • 与既往意大利暴发分离株进行系统发育比较。

主要发现

  • 9例患者在本院获得感染,通过常规或强化直肠拭子筛查检出。
  • 环境采样发现一处表面污染暴发菌株。
  • 尽管实施感染防控措施,暴发仍跨病区传播,提示及时隔离、院内患者转运和重症监护病房接触防护面临挑战。
  • 系统发育比较提示该ST147克隆存在地区性传播。

临床怎么用

  • 在高耐药菌流行率高的机构中,应加强筛查、常规监测和严格感染防控方案以防控新兴高风险克隆传播。
  • 对碳青霉烯酶肺炎克雷伯菌暴发,可结合快速分子分型与全基因组测序支持实时调查和响应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We describe an outbreak of carbapenemase-producing Klebsiella pneumoniae that occurred in February-March 2025 in a tertiary care hospital in Rome, Italy. Ten patients in two adjacent critical care units were found colonised or infected with strains co-producing NDM-1 and OXA-48 carbapenemases. Nine of these had acquired infections in our hospital and were detected through routine or enhanced rectal swab screening. Rapid implementation of infection prevention and control (IPC) measures, including patient cohorting, environmental cleaning and contact surveillance, helped contain transmission. Despite these measures, the outbreak spread across wards, suggesting challenges in timely isolation, patient movement within hospitals and contact precautions in intensive care units. Environmental sampling revealed a single surface contaminated with the outbreak strain. Rapid molecular typing using an in-house nanopore sequencing protocol (NanoTyping), supported by whole genome sequencing, confirmed clonal spread of the high-risk ST147 clone. Phylogenetic comparison with Italian isolates from previous outbreaks indicated regional dissemination of this clone. This outbreak highlights the need to combine genomic surveillance and rapid diagnostics to support real-time response. In settings with high multidrug-resistant organism (MDRO) prevalence, enhanced screening, routine surveillance and rigorous IPC protocols remain critical to prevent and control the spread of emerging high-risk clones in healthcare facilities.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Capitani V, Ceparano M, Rosso A, et al. Hospital outbreak sustained by Klebsiella pneumoniae sequence type 147 co-producing NDM-1 and OXA-48, Rome, Italy, February to March 2025: molecular tracing and control measures. Euro Surveill. 2026. PMID: 41822980. doi:10.2807/1560-7917.ES.2026.31.10.2500457

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。